HEADER HORMONE/GROWTH FACTOR 16-DEC-03 1RWE TITLE ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTAL STRUCTURE TITLE 2 AND PHOTO-CROSS-LINKING OF A8 ANALOGUES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: INSULIN A CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INSULIN; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: INSULIN B CHAIN; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES KEYWDS A8-HISTIDINE HUMAN INSULIN, INSULIN RECEPTOR, HORMONE-GROWTH FACTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.WAN,B.XU,Y.C.CHU,B.LI,S.H.NAKAGAWA,Y.QU,S.Q.HU,P.G.KATSOYANNIS, AUTHOR 2 M.A.WEISS REVDAT 6 30-OCT-24 1RWE 1 REMARK REVDAT 5 23-AUG-23 1RWE 1 REMARK REVDAT 4 27-OCT-21 1RWE 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 1RWE 1 VERSN REVDAT 2 24-FEB-09 1RWE 1 VERSN REVDAT 1 15-FEB-05 1RWE 0 JRNL AUTH Z.WAN,B.XU,K.HUANG,Y.C.CHU,B.LI,S.H.NAKAGAWA,Y.QU,S.Q.HU, JRNL AUTH 2 P.G.KATSOYANNIS,M.A.WEISS JRNL TITL ENHANCING THE ACTIVITY OF INSULIN AT THE RECEPTOR INTERFACE: JRNL TITL 2 CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES. JRNL REF BIOCHEMISTRY V. 43 16119 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 15610006 JRNL DOI 10.1021/BI048223F REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.WHITTINGHAM,S.CHAUDHURI,E.J.DODSON,P.C.MOODY,G.G.DODSON REMARK 1 TITL X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE REMARK 1 TITL 2 PRESENCE OF HELIX-STABILIZING AGENTS,THIOCYANATE, REMARK 1 TITL 3 METHYLPARAHBEN, AND PHENOL REMARK 1 REF BIOCHEMISTRY V. 34 15553 1995 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.CISZAK,J.M.BEALS,B.H.FRANK,J.C.BAKER,D.C.CARTER,G.D.SMITH REMARK 1 TITL ROLE OF C-TERMINAL B-CHAIN RESIDUES IN INSULIN ASSEMBLE: THE REMARK 1 TITL 2 STRUCTURE OF HEXAMERIC LYSB28PROB29-HUMAN INSULIN REMARK 1 REF STRUCTURE V. 3 615 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 3 REMARK 1 AUTH G.D.SMITH,R.H.BLESSING REMARK 1 TITL PHASE CHANGES IN T3R3F HUMAN INSULIN: TEMPERATURE OR REMARK 1 TITL 2 PRESSURE INSULIN REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 57 1091 2001 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444901007685 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.A.WEISS,Z.L.WAN,M.ZHAO,Y.C.CHU,S.H.NAKAGAWA,G.T.BURKE, REMARK 1 AUTH 2 W.H.JIA,R.HELLMICH,P.G.KATSOYANNIS REMARK 1 TITL NON-STANDARD INSULIN DESIGN:STRUCTURE-ACTIVITY RELATIONSHIP REMARK 1 TITL 2 AT THE PERIPHERY OF THE INSULIN RECEPTOR REMARK 1 REF J.MOL.BIOL. V. 315 103 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2001.5224 REMARK 1 REFERENCE 5 REMARK 1 AUTH Z.L.WAN,B.XU,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN , AN INACTIVE REMARK 1 TITL 2 CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 1 TITL 3 BINDING REMARK 1 REF BIOCHEMISTRY V. 42 12770 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI034430O REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 7426 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.700 REMARK 3 FREE R VALUE TEST SET COUNT : 796 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE : 0.2380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 120 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 816 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 11 REMARK 3 SOLVENT ATOMS : 136 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.61000 REMARK 3 B22 (A**2) : -1.61000 REMARK 3 B33 (A**2) : 3.23000 REMARK 3 B12 (A**2) : -0.29000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.02 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.640 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.120 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.130 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 49.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RWE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000021091. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7426 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.5200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.22400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRIES 1TRZ AND 1MPJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS, SODIUM CITRATE, ACETONE, PHENOL, REMARK 280 PH 6.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, PH 6.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.67050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.90377 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 11.56933 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 39.67050 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 22.90377 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 11.56933 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 39.67050 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 22.90377 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 11.56933 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 45.80755 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 23.13867 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 45.80755 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 23.13867 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 45.80755 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 23.13867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL REMARK 300 ASSEMBLY IS HEXAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC UNIT BY THE REMARK 300 OPERATIONS: -Y,X-Y,Z AND -X+Y,-X,Z REMARK 300 REMARK 300 THE REMARK 300 CRYSTALLOGRAPHIC ASYMMETRIC UNIT OF REMARK 300 INSULIN CONSISTS OF TWO INSULIN REMARK 300 MONOMERS EACH CONSISTING OF TWO REMARK 300 HETEROCHAINS REMARK 300 REMARK 300 REMARK 300 REMARK 300 THE ENTRY PRESENT REMARK 300 COORDINATES FOR MONOMER 1 (CHAIN REMARK 300 INDICATORS A AND B) AND MONOMER2 (CHAIN REMARK 300 INDICATORS C AND D) REMARK 300 REMARK 300 REMARK 300 THERE ARE TWO ZINC REMARK 300 IONS PER INSULIN HEXAMER LOCATED ON THE REMARK 300 THREE-FOLD AXIS REMARK 300 REMARK 300 THE CONFORMATIONS REMARK 300 OF TWO MONOMERS ARE DIFFERENT AS THE REMARK 300 RESULT OF B CHANGE IN CONFORMATION OF REMARK 300 FIRST EIGHT RESIDUES OF THE B-CHAIN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -124.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -157.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 19030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -319.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN B 201 LIES ON A SPECIAL POSITION. REMARK 375 CL CL B 202 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN D 301 LIES ON A SPECIAL POSITION. REMARK 375 CL CL D 302 LIES ON A SPECIAL POSITION. REMARK 375 HOH D 303 LIES ON A SPECIAL POSITION. REMARK 375 HOH D 304 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 3 70.14 -118.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS B 10 NE2 106.0 REMARK 620 3 HIS B 10 NE2 106.0 106.0 REMARK 620 4 CL B 202 CL 112.8 112.8 112.8 REMARK 620 5 CL B 202 CL 112.8 112.8 112.8 0.0 REMARK 620 6 CL B 202 CL 112.8 112.8 112.8 0.0 0.0 REMARK 620 7 HOH B 203 O 87.6 165.6 73.9 56.0 56.0 56.0 REMARK 620 8 HOH B 203 O 165.6 73.9 87.6 56.0 56.0 56.0 91.8 REMARK 620 9 HOH B 203 O 73.9 87.6 165.6 56.0 56.0 56.0 91.8 91.8 REMARK 620 N 1 2 3 4 5 6 7 8 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS D 10 NE2 106.7 REMARK 620 3 HIS D 10 NE2 106.7 106.7 REMARK 620 4 CL D 302 CL 112.1 112.1 112.1 REMARK 620 5 CL D 302 CL 112.1 112.1 112.1 0.0 REMARK 620 6 CL D 302 CL 112.1 112.1 112.1 0.0 0.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MPJ RELATED DB: PDB REMARK 900 X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE REMARK 900 PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN, REMARK 900 AND PHENOL DBREF 1RWE A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 1RWE C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 1RWE B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 1RWE D 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 1RWE HIS A 8 UNP P01308 THR 97 ENGINEERED MUTATION SEQADV 1RWE HIS C 8 UNP P01308 THR 97 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS HIS SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS HIS SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR HET ZN B 201 1 HET CL B 202 1 HET IPH C 200 7 HET ZN D 301 1 HET CL D 302 1 HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM IPH PHENOL FORMUL 5 ZN 2(ZN 2+) FORMUL 6 CL 2(CL 1-) FORMUL 7 IPH C6 H6 O FORMUL 10 HOH *136(H2 O) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 GLU A 17 1 6 HELIX 3 3 ASN A 18 CYS A 20 5 3 HELIX 4 4 GLY B 8 GLY B 20 1 13 HELIX 5 5 GLU B 21 GLY B 23 5 3 HELIX 6 6 GLY C 1 CYS C 7 1 7 HELIX 7 7 SER C 12 GLU C 17 1 6 HELIX 8 8 ASN C 18 CYS C 20 5 3 HELIX 9 9 VAL D 2 GLY D 20 1 19 HELIX 10 10 GLU D 21 GLY D 23 5 3 SHEET 1 A 2 PHE B 24 TYR B 26 0 SHEET 2 A 2 PHE D 24 TYR D 26 -1 O TYR D 26 N PHE B 24 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.03 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.02 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.03 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.03 LINK NE2 HIS B 10 ZN ZN B 201 1555 1555 2.02 LINK NE2 HIS B 10 ZN ZN B 201 2555 1555 2.02 LINK NE2 HIS B 10 ZN ZN B 201 3555 1555 2.02 LINK ZN ZN B 201 CL CL B 202 1555 1555 2.25 LINK ZN ZN B 201 CL CL B 202 1555 2555 2.25 LINK ZN ZN B 201 CL CL B 202 1555 3555 2.25 LINK ZN ZN B 201 O HOH B 203 1555 1555 2.43 LINK ZN ZN B 201 O HOH B 203 1555 3555 2.43 LINK ZN ZN B 201 O HOH B 203 1555 2555 2.43 LINK NE2 HIS D 10 ZN ZN D 301 1555 1555 2.06 LINK NE2 HIS D 10 ZN ZN D 301 3555 1555 2.06 LINK NE2 HIS D 10 ZN ZN D 301 2555 1555 2.06 LINK ZN ZN D 301 CL CL D 302 1555 1555 2.26 LINK ZN ZN D 301 CL CL D 302 1555 2555 2.26 LINK ZN ZN D 301 CL CL D 302 1555 3555 2.26 SITE 1 AC1 3 HIS B 10 CL B 202 HOH B 203 SITE 1 AC2 2 HIS D 10 CL D 302 SITE 1 AC3 4 HIS B 10 ZN B 201 HOH B 203 HOH B 238 SITE 1 AC4 3 HIS D 10 ZN D 301 HOH D 304 SITE 1 AC5 5 CYS C 6 ILE C 10 CYS C 11 HIS D 5 SITE 2 AC5 5 LEU D 11 CRYST1 79.341 79.341 34.708 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012604 0.007277 0.000000 0.00000 SCALE2 0.000000 0.014554 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028812 0.00000